Introduction
The incidence of adenocarcinoma at the esophagogastric junction (EGJ) has increased in the West [1] [2] [3] [4] . Some reports indicate that the same trend is occurring in Japan [5] , but adenocarcinoma of the EGJ is still rare here, and adenocarcinoma of the esophagus is even rarer. The definition of adenocarcinoma of the EGJ is obscure, and in many advanced cancer cases, it is difficult to know whether the tumor is junctional in origin or a result of invasion to the EGJ from sites distal or proximal to it. To investigate junctional cancers, we studied cases of adenocarcinoma that fulfill Siewert's type II criterion (being tumors the center of which is located within 1 cm oral and 2 cm distal of the anatomical EGJ) [6] . We investigated tumors less than 4 cm in maximum diameter, because the architecture of the EGJ was still preserved in the presence of such small tumors, and the background mucosae of the carcinoma, in terms of the squamocolumnar junction (SCJ), cardiac glands, oxyntic glands, intestinal metaplasia, and Barrett's epithelium, were easily studied. We also investigated p53 protein overexpression, because significantly high levels of p53 mutations and p53 protein overexpression in cardia and esophageal adenocarcinomas have been reported in the West [7, 8] . In this study, we investigated the characteristics of junctional carcinoma and background mucosa in Japanese patients to find the similarities with and differences from Western patients.
therapy. Gross specimens were opened along the longitudinal axis of the stomach. We identified the EGJ in resected materials to be where the tubular esophagus joins the saccular stomach (Fig. 1) , and the SCJ was the visible line formed by the juxtaposition of squamous and columnar epithelia. The carcinomas were classified into two types: tumors straddling the EGJ (EGJ-type; Fig. 2A) , and tumors occurring entirely below the EGJ (bEGJ-type; Fig. 2B ).
All specimens were fixed in 10% formalin and cut serially into 5-mm slices parallel with the lesser curvature. All tissue sections were stained with hematoxylineosin. Tumors were characterized by gross type, histological type, depth of invasion, and lymph node involvement. Barrett's epithelium was diagnosed when columnar epithelium was continuously found from the EGJ to the distal esophagus, and Barrett's metaplasia was diagnosed only when incomplete intestinal metaplasia was found in Barrett's epithelia. The state of the oxyntic gland was also evaluated. Atrophy of the oxyntic gland was graded into four categories: none, mild, moderate, and severe atrophy. The "none" and "mild" categories were considered as negative and the "moderate" and "severe" categories were considered as positive for atrophy. Intestinal metaplasia of the stomach was also evaluated. If intestinal metaplasia was detected in none to a few slides of the stomach tissue, patients with this finding were considered negative for intestinal metaplasia. If intestinal metaplasia was detected in many to all slides of the stomach tissue, patients with this finding were considered positive for intestinal metaplasia. Fig. 1 . Photograph of the exophagogastric junction (EGJ) in a patient with short segment Barrett's esophagus. We defined the EGJ as the area where the tubular esophagus joins the saccular stomach (center line). Siewert type II junctional adenocarcinoma is that which arises between 1 cm oral (right line) and 2 cm distal (left line) of the EGJ Fig. 2A 
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Statistical methods
Frequencies of various characteristics were compared between groups, and the 2 test with Fisher's exact test was used to test for statistical differences. Statistical significance was accepted at a P value of less than 0.05.
Results
Patient characteristics
The clinicopathological characteristics of all 54 patients are shown in Table 1 . There were 23 (43%) EGJ-type patients and 31 (57%) bEGJ-type patients. The average age of all patients was 64 years (range, 45-80 years); 52% of the EGJ-type patients and 74% of the bEGJtype were aged 60 years or more. Men comprised 78% of the EGJ-type patients and 87% of the bEGJ-type patients.
Tumor characteristics
The frequency of advanced cancer was significantly higher in EGJ-type tumors than in bEGJ-type tumors (52% in EGJ-type vs 26% in bEGJ-type; P Ͻ 0.05). Most of the advanced gastric cancers in the EGJ-type carcinomas were grossly identified as type-2 tumors. Histologically, 65% of EGJ-type and 58% of bEGJtype carcinomas were classified as tubular adenocarcinoma. Signet ring cell carcinoma was seen in only one patient, with a bEGJ-type tumor. Ninety percent of bEGJ-type cancers and 61% of EGJ-type cancers were node-negative (Table 1) .
Phenotypic expression of mucin, and mucin and p53 expression in the tumor cells
Twelve of 23 (52%) EGJ-type tumors expressed human gastric mucin, whereas only 29% of bEGJ-type tumors did so. About 55% of both tumor types expressed Muc-2 glycoprotein. (Table 2 ) Thirty-nine percent of EGJtype tumors were of the mixed gastric and intestinal phenotype (Table 3 ; Fig. 3A-D) , whereas 38% of bEGJ-type tumors were of the intestinal phenotype (Table 3 ; Fig. 4A-C) . p53 protein was detected in 78% of EGJ-type tumors and 55% of bEGJ-type tumors (Table 4) ; none of these differences were statistically significant (Tables 2, 3, 4) .
Surrounding mucosa
The SCJ and EGJ coincided in 48 of the 54 (89%) patients. Six patients (11%) had tongue-like or circular Barrett's epithelia. Barrett's metaplasia was seen in only 2 patients, with EGJ-type tumors, and both were of the short-segment Barrett's esophagus type. Cardiac glands around the EGJ were seen in most cases. Extension of cardiac glands distal to the EGJ was from 2 mm to 16 mm, and oral extension into the distal esophagus was from 0 mm to 10 mm. Atrophy of the oxyntic glands was significantly less frequent in EGJ-type than in bEGJ-type patients (26% of EGJ-type vs 77% of bEGJtype; P Ͻ 0.01). Intestinal metaplasia of the stomach was also significantly less frequent in EGJ-type patients (22% vs 52%; P Ͻ 0.05). H. pylori infection was seen in 26% of EGJ-type and 35% of bEGJ-type patients (Table 5) . Dysplasia within Barrett's metaplasia was not observed. In one case patient with signet ring cell carcinoma, dense oxyntic glands were seen in the surrounding mucosa.
Discussion
The gastric cardia or gastroesophageal junction is a vague anatomical area; foveolar epithelium, stratified squamous epithelium, and in some cases, intestinal metaplasia are seen, and cardiac and oxyntic glands are also seen in this area. Some investigators believe that cardiac mucosa is not normal mucosa but, rather, mucosa acquired as a result of gastroesophageal reflux [10] . Gastroesophageal reflux disease (GERD) occurs less frequently in Japan than in the Western world, but in our study, cardiac mucosa was seen in most patients. Distal extension of cardiac glands from the EGJ was from 2 mm to 16 mm in our study, and cardiac mucosa appeared to occupy only a small part of Siewert's type II areas, as other investigators have also reported [11] [12] [13] .
With regard to the sex and age of patients with EGJ adenocarcinoma in the Western world, a strong predilection exists for middle-aged and older white men [14, 15] ; likewise, in our Japanese series, both EGJ-and bEGJ-type patients were predominantly old men. Many of the EGJ-type carcinomas were advanced cancers, and the ratio of type-2 carcinoma was high, indicating that EGJ-type carcinomas tend to have a penetrating, expansive growth pattern, whereas bEGJ-type carcinomas tend to have a superficial spreading growth pattern.
Microscopically, both types of carcinomas were predominantly well differentiated, and signet ring cell carcinoma was not found in any EGJ-type patients. The phenotypic expression of mucin was also slightly different between the EGJ-and bEGJ-type carcinomas. Tajima et al. [16] reported high positivity for gastric phenotype markers alone in early adenocarcinoma of the gastric cardia. Of our EGJ-type tumors, 52% reacted with human gastric mucin, but many of them also reacted with intestinal mucin, and many of the bEGJtype tumors were of the pure intestinal phenotype. High levels of p53 protein expression have been reported in gastric cardia tumors (56%-65%) and also in esophageal adenocarcinoma (59%), in comparison to levels in adenocarcinoma of the antrum (27%) [7, 8] . In the present series, 78% of the EGJ-type and 55% of bEGJtype tumors expressed p53 protein. The percentage of p53 protein expression was higher in EGJ-type and lower in bEGJ-type carcinomas in comparison with findings in other studies.
In the gastric mucosa of EGJ-type tumors vs that of bEGJ-type tumors, oxyntic glands were better preserved, intestinal metaplasia was less frequent, and the H. pylori infection rate was lower. In distal gastric cancer, H. pylori infection, chronic atrophic gastritis, and intestinal metaplasia are thought to constitute the pathway to carcinogenesis [17] . EGJ-type tumors appear to be not related to this pathway, and they expressed p53 protein. These characteristics are similar to those of cardia adenocarcinoma in Western patients, but in our series, Barrett's metaplasia was detected in only two patients (3.8%), and the frequency of Barrett's metaplasia is much less in Japanese than in Western people (13%-42%) [18] [19] [20] . In the present study of small Siewert type II junctional cancers, the number of tumors that did not cross the EGJ (bEGJ-type) was larger than the number that did (EGJ-type). This type of tumor may cross the EGJ through tumor extension. The advanced junctional cancer in many Japanese patients appears to originate from subjunctional mucosa. The H. pylori infection rate is now very high in the Japanese population, and eradication therapy has just begun to be used routinely. Fortunately, the infection rate in the younger generation in Japan is low. The incidence of EGJ-type may increase in the near future, but at present we do not know whether the incidence of junctional adenocarcinoma either with or without Barrett's metaplasia will increase.
In conclusion, there are two different type of EGJ adenocarcinoma in Japan, based on different associations with atrophy and intestinal metaplasia of the stomach. EGJ-straddling tumors have less intestinal metaplasia and oxyntic gland atrophy of the stomach than tumors occurring entirely below the EGJ. EGJstraddling tumors appear to be the Western-type junctional adenocarcinoma that is still rare in Japan. Many cases of advanced junctional adenocarcinoma in Japan are of subjunctional origin.
